Subgroups
Outcomes (4)
Protocols & scoring
medication-avapritinib-oral-daily1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-tryptase-serum-reduction-greater-than-50-percent-rate | +88 | 65 | 52 |
medication-midostaurin-oral-twice-daily1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-tryptase-serum-reduction-greater-than-50-percent-rate | +45 | 55 | 26 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-tryptase-serum-reduction-from-187-to-19-ng-per-ml | +85 | 45 | 1 |
medication-midostaurin-twice-daily1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-tryptase-serum-decrease | +15 | 45 | 20 |
medication-naltrexone-low-dose1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| biomarker-tryptase-level-normalization-self-reported | +70 | 25 | 1 |
Path: biomarker › tryptase